BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src AND Treatment
225 results:

  • 1. Steroid receptor coactivator 1 promotes human hepatocellular carcinoma invasiveness through enhancing MMP-9.
    Tong Z; Zhang Y; Guo P; Wang W; Chen Q; Jin J; Liu S; Yu C; Mo P; Zhang L; Huang J
    J Cell Mol Med; 2024 Apr; 28(7):e18171. PubMed ID: 38506084
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Tyrosine phosphatase
    Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
    Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. FGF2 drives osteosarcoma metastasis through activating FGFR1-4 receptor pathway-mediated ICAM-1 expression.
    Huang YC; Chen WC; Yu CL; Chang TK; I-Chin Wei A; Chang TM; Liu JF; Wang SW
    Biochem Pharmacol; 2023 Dec; 218():115853. PubMed ID: 37832794
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Network pharmacology and molecular docking to explore the mechanism of Sheng Xue Bao mixture against iron deficiency anemia.
    Wang Y; Qinqin H; Wang H; Zhang H; Zhang X; Liu W; Xiang Z; Gu Y
    Medicine (Baltimore); 2023 Sep; 102(37):e35012. PubMed ID: 37713882
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A Triazaspirane Derivative Inhibits Migration and Invasion in PC3 prostate cancer Cells.
    Vasconcelos-Ulloa JJ; García-González V; Valdez-Salas B; Vázquez-Jiménez JG; Rivero-Espejel I; Díaz-Molina R; Galindo-Hernández O
    Molecules; 2023 Jun; 28(11):. PubMed ID: 37299000
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Intratumoral Restoration of miR-137 Plus Cholesterol Favors Homeostasis of the miR-137/Coactivator p160/AR Axis and Negatively Modulates Tumor Progression in Advanced prostate cancer.
    Pimenta R; Mioshi CM; Gonçalves GL; Candido P; Camargo JA; Guimarães VR; Chiovatto C; Ghazarian V; Romão P; da Silva KS; Dos Santos GA; Silva IA; Srougi M; Nahas WC; Leite KR; Viana NI; Reis ST
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298588
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Systematic investigation of the mechanism of herbal medicines for the treatment of prostate cancer.
    Wang J; Ding R; Ouyang T; Gao H; Kan H; Li Y; Hu Q; Yang Y
    Aging (Albany NY); 2023 Feb; 15(4):1004-1024. PubMed ID: 36795572
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. pNaktide mitigates inflammation-induced neuronal damage and behavioral deficits through the oxidative stress pathway.
    Zong Q; Pan Y; Liu Y; Wu Z; Huang Z; Zhang Y; Ma K
    Int Immunopharmacol; 2023 Mar; 116():109727. PubMed ID: 36689848
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Risk of secondary tumours in patients with non-metastatic and metastatic human retinoblastoma.
    Sadeghi R; Pirankuraim H; Javanshir ST; Arabi M; Bereimipour A; Javanshir HT; Mahmoodzadeh H; Nayernia K
    Eye (Lond); 2023 Aug; 37(11):2327-2334. PubMed ID: 36528757
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Deregulation of SPOP in cancer.
    Zhang H; Jin X; Huang H
    Cancer Res; 2023 Feb; 83(4):489-499. PubMed ID: 36512624
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Inhibiting ACK1-mediated phosphorylation of C-terminal src kinase counteracts prostate cancer immune checkpoint blockade resistance.
    Sridaran D; Chouhan S; Mahajan K; Renganathan A; Weimholt C; Bhagwat S; Reimers M; Kim EH; Thakur MK; Saeed MA; Pachynski RK; Seeliger MA; Miller WT; Feng FY; Mahajan NP
    Nat Commun; 2022 Nov; 13(1):6929. PubMed ID: 36376335
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Apelin Promotes prostate cancer Metastasis by Downregulating TIMP2 via Increases in miR-106a-5p Expression.
    Lin TH; Chang SL; Khanh PM; Trang NTN; Liu SC; Tsai HC; Chang AC; Lin JY; Chen PC; Liu JF; Guo JH; Liu CL; Wu HC; Tang CH
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291151
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. CUB Domain-Containing Protein 1 (CDCP1) is a rational target for the development of imaging tracers and antibody-drug conjugates for cancer detection and therapy.
    Khan T; Lyons NJ; Gough M; Kwah KKX; Cuda TJ; Snell CE; Tse BW; Sokolowski KA; Pearce LA; Adams TE; Rose SE; Puttick S; Pajic M; Adams MN; He Y; Hooper JD; Kryza T
    Theranostics; 2022; 12(16):6915-6930. PubMed ID: 36276654
    [No Abstract]    [Full Text] [Related]  

  • 14. Mechanism of saikogenin G against major depressive disorder determined by network pharmacology.
    Hu L; Wang J; Zhao X; Cai D
    Medicine (Baltimore); 2022 Aug; 101(34):e30193. PubMed ID: 36042622
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Androgen receptor variant-7 regulation by tenascin-c induced src activation.
    Thomas R; Jerome JM; Dang TD; Souto EP; Mallam JN; Rowley DR
    Cell Commun Signal; 2022 Aug; 20(1):119. PubMed ID: 35948987
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Disassembly of α6β4-mediated hemidesmosomal adhesions promotes tumorigenesis in PTEN-negative prostate cancer by targeting plectin to focal adhesions.
    Wenta T; Schmidt A; Zhang Q; Devarajan R; Singh P; Yang X; Ahtikoski A; Vaarala M; Wei GH; Manninen A
    Oncogene; 2022 Jul; 41(30):3804-3820. PubMed ID: 35773413
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Targeting CDCP1 gene transcription coactivated by BRD4 and CBP/p300 in castration-resistant prostate cancer.
    Ji D; Shang G; Wei E; Jia Y; Wang C; Zhang Q; Zeng L
    Oncogene; 2022 Jun; 41(23):3251-3262. PubMed ID: 35513563
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Melatonin suppresses the metastatic potential of osteoblastic prostate cancers by inhibiting integrin α
    Tai HC; Wang SW; Swain S; Lin LW; Tsai HC; Liu SC; Wu HC; Guo JH; Liu CL; Lai YW; Lin TH; Yang SF; Tang CH
    J Pineal Res; 2022 Apr; 72(3):e12793. PubMed ID: 35174530
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Protein tyrosine phosphatase 1B(PTP1B) promotes melanoma cells progression through src activation.
    Wang Q; Pan Y; Zhao L; Qi F; Liu J
    Bioengineered; 2021 Dec; 12(1):8396-8406. PubMed ID: 34606417
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Screening tumor specificity targeted by arnicolide D, the active compound of Centipeda minima and molecular mechanism underlying by integrative pharmacology.
    Yao J; Shen Q; Huang M; Ding M; Guo Y; Chen W; Lin Y; Zheng Y; Yu S; Yan W; Su T; Liu Z; Lu L
    J Ethnopharmacol; 2022 Jan; 282():114583. PubMed ID: 34487850
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 12.